High Quality IVF Center in Israel – The Affordable Solution for Overseas Patients

Other Publications

  • Kol S, Adashi EY. Intra-ovarian factors regulating ovarian function. Current Opinions in Obsterics and Gynecology, 7:209, 1995. Full text
  • Kol S, Rohan RM and Adashi EY (2000). The role of growth factors in ovarian function and development. In: Sciarra JJ (Ed.), Gynecology and Obstetrics, Lippincott Williams and Wilkins, Philadelphia, PA. Vol. 5, 11:1-13. Full text
  • Itskovitz-Eldor J, Kol S. Disorders of the gonadotrophs. In: Reproductive Endocrinology, Surgery and Technology. Adashi EY, Rock JA, Rosenwaks Z Editors, Raven Press, NY (1996). Full text
  • Kol S, Itskovitz-Eldor J. Triggering ovulation with GnRH analogs. In: Serono Symposia. Ovulation: Evolving Scientific and Clinical Concepts. Eki Y. Adashi, Editor. Springer-Verlag, New York, Inc. 2000, pp. 308-316.
  • Kol S. Hormonal Therapy of the Infertile Woman. In: “Contemporary Endocrinology: Hormone Replacement Therapy”, second edition. Editor: Wayne Meikle, pp 525-536, 2003, Humana Press, Totowa, NJ. Full text
  • Kol S. Assisted Reproductive Technology. In: Encyclopedia of Endocrinology and Endocrine Diseases. Editor-in-Chief Luciano Martini, 2004, Academic Press, San Diego. California. Full text
  • Weissman A, Kol S, Peretz BA. Gas embolism in obstetrics and gynecology. J Reprod Med 41:103-111, 1996. Full text
  • Kol S, Adir Y, Shupak A, Stahl S. Adjuvant hyperbaric oxygenation therapy in hand edema and ischemia. Techniques in Hand and Upper Extremity Surgery 2:274-277, 1998. Full text
  • Kent-First MG, Kol S, Muallem A, Blazer S, Itskovitz-Eldor J. Infertility in intracytoplasmic-perm-injection-derived sons. Lancet 348:332, 1996. Full text
  • Kol S. Medical examination of rape victims. Medicine and Law 15:59, 1996. Full text
  • Kol S, Lewit N, Itskovitz-Eldor J. Ovarian hyperstimulation syndrome: modern concepts in pathophysiology and management. Mid East Fertil Soc J 1:246, 1996. Full text
  • Kol S. Oocyte donation: the shortage and a possible solution. Medicine and Law 19:74-77, 1998. Full text
  • Fertilization method is linked to gene defect. Washington Post, February 20, 1997. Full text
  • GnRH agonist instead of hCG to trigger ovulation in GnRH antagonist cycles. ESHRE Campus, Brussels, December 10th, 2004. GnRH antagonists in ovarian stimulation for IVF, Concensus workshop Group.
  • Kol S, Itskovitz-Eldor J. Society’s contribution to assisted reproductive technology abuse. Hum. Reprod. 20:2362, 2005. Full text
  • Kol S . Luteal support post GnRH agonist trigger: do not stop too soon. Human Reproduction 20:3257, 2005 Full text
  • Kol S. Does ovulation triggering influence the risk of OHSS? In “Ovarian Hyperstimulation Syndrome. Chapter 20. Edited by Gerris, Olivennes, Delvingne, Taylor&Francis. 2006 Full text
  • Kol S. Agonist trigger in the context of OHSS prevention: primum non nocere . Human Reproduction Update, advanced access published March 31, 2006. Full text
  • Kol S. GnRH agonist trigger: looking for the coin under the lamp post? Human Reproduction 21:1328, 2006. Full text
  • Prevention of OHSS. Serono Symposia, St. Petersburg, Russia, May 5-6, 2006. Microsoft Powerpoint presentation
  • Advanced age fertility: Can we improve the results? The 10th Annual Meeting of the Israeli Society for Community Gynecology, Israel, October 17, 2007. Microsoft Powerpoint presentation
  • Kol S Ultrasound-guided embryo transfer – a special role in patients with certain uterine defects. Fertil Steril. 2008, 89(1):260 Full text
  • Kol S The vanishing follicle in women aged over forty: Premature, mechanical, LH-independent luteinization may reflect oocyte-follicle low quality?Med Hypotheses. 2008 Jan 10Full text
  • R. Homburg, Kol S Letter to the Editor: Reply: Investigating actions of changing hormone levels. Human Reproduction, doi:10.1093/humrep/den307 Full text
  • Kol S. Does GnRHa triggering completely abolish OHSS? GnRH agonist for triggering of final oocyte maturation – time for a paradigm shift. ESHRE Campus, Madrid, Spain, 3 December 2010Microsoft Powerpoint presentation
  • Kol S, Rohan RM and Adashi EY (2008). The role of growth factors in ovarian function and development. In: The Global Library of Women’s Medicine. Full text
  • Kol S, A case of severe early-onset OHSS after GnRH-agonist triggering. Letter to the Editor. Fertil Steril. 96:e151, 2011 Full text
  • Kol S, (2011). Ovarian hyperstimulation prevention. In: The Global Library of Women’s Medicine Full text
  • Kol S, OHSS: Should this be treated or prevented? Asia Pacific COGI conference, Bangkok, Thailand, November 2011. COGI Bangkok Kol
  • P. Humaidan, S. Kol, E.G. Papanikolaou, L. Engmann, C. Benadiva, J. Itskovitz-Eldor, E.J. Margalioth, E. Ricciarelli, D. Bodri, J.C. Castillo-Farfan, J.A. Garcia-Velasco, C. Yding Andersen, P. Devroey and B. Tarlatzis. Reply:  GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Hum. Reprod. Update 2012 18: 229-230.  Full text
  •  Kol S. Prevention of OHSS. Updates in Infertility Treatment, Budapest, Hungary, 8-10 February, 2012.  PPTX presentation, Live lecture (video)
  • Kol S. GnRH-a to trigger ovulation should be used in all PCOS patients to prevent OHSS. COGI conference, Singapore, July 2012. PPTX presentation
  • Kol S. Individualized treatment from theory to practice: the private case of adding LH during GnRH antagonist based stimulation protocol. 11th Internatinal Symposium on GnRH, February 9-11, 2014, Salzburg, Austria.  PPTX presentation
  • Kol S.OHSS prevention: Yes, we can! 11th Internatinal Symposium on GnRH, February 9-11, 2014, Salzburg, Austria.  PPTX presentation
  • Kol S.IVF 2020, Maccabi Health Care, February 2014.  PPTX presentation
  • Kol S. GnRH agonist and individualized luteal phase hCG support will avoid OHSS in PCOS. Toward friendly stimulation in Assisted Reproductive Technology. Hillel Yafe, Hadera Israel, March 2014.  PPTX presentation

IVF at Israel

With unbeatable success rates and an affordable, competitive price, IVF treatment in Israel enjoys popularity and prestige among overseas patients.